Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 28, 2024 08:55 ET | Source: SciSparc Ltd

SciSparc Grants Global Rights for Pain Therapy to Biotech Company in Agreement Worth up to $6 Million

SciSparc would be entitled to receive consideration valued at $3 million in Polyrizon securities, as well as potential milestone fees of approximately $3 million in cash TEL AVIV, Israel, Aug. 28,...
July 18, 2022 08:00 ET | Source: Medigus Ltd

Medigus: Polyrizon Signed an Agreement with Nurexone for Intranasal Administration of Cutting - Edge Therapy for Spinal Cord Injuries

Polyrizon will be entitled for up to $3.35 million in addition to future royalties Tel Aviv, Israel, July 18, 2022 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged...
July 01, 2022 08:30 ET | Source: Medigus Ltd

Medigus: Eventer Signs Agreements with Two Teams from the Israeli Basketball Premier League and the Israeli National Basketball League

Eventer will leverage its capabilities in the sports sector and intends to expand its outreach to leagues in the US and Europe Tel Aviv, Israel, July 01, 2022 (GLOBE NEWSWIRE) -- Medigus...
May 31, 2022 08:30 ET | Source: SciSparc Ltd

SciSparc to Collaborate with Polyrizon for Brain Targeting Using Intranasal Hydrogel Systems

SciSparc will use its SCI-160 technology platform for treating pain in combination with Polyrizons' Trap and TargetTM technology TEL AVIV, Israel, May 31, 2022 (GLOBE NEWSWIRE) -- SciSparc Ltd....